Do natural variations in hormones, such as oestrogen, make anxiety disorders more likely? If so does this affect the way people respond to treatment?
A computational approach to identifying trans-diagnostic predictors of antidepressant response
Dr Claire Gillan is creating an internet-based tool which could predict how effective antidepressants will be for different individuals.
The project
Imagine if we could accurately predict which types of antidepressant would be most effective for people living with depression?
Right now, one in ten people experience depression in the UK. Millions turn to their doctor each year – but without precise tools to know which treatment is most suitable, many may be given treatment that doesn’t work for them. For drug treatments, such as antidepressants – it often takes several attempts before finding something that is works.
This trial and error approach means many people may endure months of little improvement and unnecessary side effects. Recovery and wellbeing often suffers as a result.
So, Dr Claire Gillan at Trinity College Dublin will be investigating whether a simple new tool that uses internet-based techniques could provide the information needed to transform treatment of depression. She’s designing a tool that could make sure the right treatments are reaching the right patients – by predicting how well each individual will respond to treatment.
The process
To create this tool, Claire will collect data online from people who are new to antidepressants.
Participants will share information about themselves online and take part in online cognitive tests to determine and track their symptoms.
This data will enable Claire to create an algorithm to estimate how well people with certain characteristics will respond to specific treatments.
The algorithm will then be tested in local clinics with patients who have been diagnosed with depression – and with other conditions like Obsessive Compulsive Disorder (OCD).
By using the internet in this way, Claire will be exploring important new ways to conduct treatment research.
The potential
Claire’s project has the power to transform the way we personalise treatment for depression – meaning millions of people could be given more effective support.
As well as enabling people to get better faster, the work could also enable health services to radically reduce the amount spent on ineffective treatments.
In January 2017, Dr Claire Gillan will open a new lab and take up a post as assistant professor of Psychology at Trinity College Dublin. She completed a Ph.D. at Cambridge University and gained a postdoctoral fellowship at New York University. She is passionate about understanding and treating mental health problems through research.
Was this information helpful?
Related research profiles
Sensitive periods for the effects of depression on suicide risk: a longitudinal study of gene-environment interactions and epigenetic mechanisms
Dr Lussier aims to determine the extent to which child and adolescent depression interacts with genetic susceptibility to influence suicide risk in early adulthood.
Increasing access to social prescribing for people living with severe mental illnesses at risk of cardiovascular disease
People with severe mental illnesses are at high risk of heart disease due to lack of physical activity and social isolation. Social prescribing can help, but is it accessible?